3 completed, 2 terminated. 5 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 3, Terminated 2 |
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow Carcinoma, Islet Cell: new trials by email Literature Review of Carcinoma, Islet Cell trials Research Report on Carcinoma, Islet Cell
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Fentanyl sublingual spray, Placebo - Cancer | Phase 3 | Completed | INSYS Therapeutics Inc | 130 | 2007-10-01 | 2014-03-05 |
| A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors sunitinib malate, Placebo - Carcinoma, Islet Cell, Carcinoma, Pancreas | Phase 3 | Terminated | Pfizer | 171 | 2007-06-01 | 2010-10-11 |
| Cinacalcet to Treat Familial Primary Hyperparathyroidism Parathyroid hormone testing, Serum calcium testing - Hypercalcemia, Familial Primary Hyperparathyroidism | Phase 3 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 25 | 2006-05-09 | 2017-07-02 |
| Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors Indium-111 pentetreotide - Neuroendocrine Tumors | Phase 2 / Phase 3 | Completed | Radio Isotope Therapy of America | 200 | 2005-08-01 | 2023-04-03 |
| Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors bevacizumab, 5-fluorouracil, leucovorin - Gastrointestinal Carcinoid Tumor, Islet Cell Tumor | Phase 2 / Phase 3 | Terminated | University of California, San Francisco | 36 | 2005-06-08 | 2023-05-22 |
Gastrinoma (3) · Insulinoma (3) · Somatostatinoma (3) · Glucagonoma (2) · Neoplasms (2) · Neuroendocrine Tumors (2) · Pancreatic Neoplasms (2) · Vipoma (2) · Adenoma, Islet Cell (1) · Adrenocortical Carcinoma (1) · Anus Neoplasms (1) · Appendiceal Neoplasms (1) · Astrocytoma (1) · Bile Duct Neoplasms (1)
Adenocarcinoma (5) · Carcinoma (5) · Digestive System Diseases (5) · Digestive System Neoplasms (5) · Endocrine Gland Neoplasms (5) · Endocrine System Diseases (5) · Neoplasms by Histologic Type (5) · Neoplasms by Site (5) · Neoplasms, Glandular and Epithelial (5) · Pancreatic Diseases (5) · Carcinoma, Neuroendocrine (4) · Neoplasms, Germ Cell and Embryonal (4) · Neoplasms, Nerve Tissue (4) · Neuroectodermal Tumors (4) · Adenoma (3)
Bevacizumab (1) · Fentanyl (1) · Fluorouracil (1) · Leucovorin (1) · Oxaliplatin (1) · Sunitinib (1)
INSYS Therapeutics Inc (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · Pfizer (1) · Radio Isotope Therapy of America (1) · University of California, San Francisco (1)
United States (5) · Australia (1) · Belgium (1) · Canada (1) · France (1) · Germany (1) · Italy (1) · South Korea (1) · Spain (1) · Taiwan (1) · United Kingdom (1)
Ebrahim Delpassand, M.D. (1) · Emily K. Bergsland, MD (1) · Larry Dillaha, MD (1)
PMID 21306237, PMID 22480131, PMID 27020837, PMID 27836885, PMID 27924459, PMID 29161241, PMID 33411058